Oncology

Our oncology portfolio provides cancer patients with a broad range of therapies and practical solutions for the treatment of cancer and hematology. These include:

  • Afinitor/Votubia (everolimus)
  • Exjade (deferasirox)
  • Femara (letrozole)
  • Gleevec/Glivec (imatinib mesylate/imatinib)
  • Jakavi (ruxolitinib)
  • Sandostatin LAR/Sandostatin SC (octreotide acetate for injectable suspension/octreotide acetate)
  • Tasigna (nilotinib)
  • Zometa (zoledronic acid)

 

Visit the Novartis Oncology Websites: